Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BBLN NASDAQ:BTTX NASDAQ:EUDA NYSE:UPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLNBabylon$0.55$0.60$0.46▼$28.50$14.10M2.42415,159 shsN/ABTTXBetter Therapeutics$0.00$0.00$0.00▼$0.01$5K0.9616,426 shs421 shsEUDAEUDA Health$3.25+0.6%$3.57$2.92▼$6.30$120.05M-0.0484,298 shs79,230 shsUPHUpHealth$0.73$0.25▼$3.19$5.33M0.51121,201 shs348,700 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLNBabylon0.00%0.00%0.00%0.00%0.00%BTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-99.07%EUDAEUDA Health+0.62%+2.20%-9.72%-19.55%-15.58%UPHUpHealth0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLNBabylonN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AEUDAEUDA Health1.2536 of 5 stars0.05.00.00.03.30.00.6UPHUpHealthN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLNBabylon 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/AEUDAEUDA Health 4.00Strong BuyN/AN/AUPHUpHealth 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLNBabylon$1.15B0.01N/AN/A($10.29) per share-0.05BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AEUDAEUDA Health$4.01M30.12N/AN/A($0.07) per share-46.43UPHUpHealth$153.15M0.00N/A0.18$7.05 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLNBabylon-$221.45M-$23.03N/A∞N/A-35.54%N/A-105.06%N/ABTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)EUDAEUDA Health-$15.36MN/A0.00N/AN/AN/AN/AN/A7/29/2025 (Estimated)UPHUpHealth-$223M-$4.50N/AN/AN/A-49.08%12.33%3.66%N/ALatest BTTX, UPH, EUDA, and BBLN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025N/AEUDAEUDA Health-$0.02N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLNBabylonN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AUPHUpHealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLNBabylonN/A1.071.07BTTXBetter TherapeuticsN/AN/AN/AEUDAEUDA HealthN/A0.180.15UPHUpHealthN/A0.130.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLNBabylon37.90%BTTXBetter Therapeutics34.00%EUDAEUDA Health4.35%UPHUpHealth23.35%Insider OwnershipCompanyInsider OwnershipBBLNBabylon38.52%BTTXBetter Therapeutics51.40%EUDAEUDA HealthN/AUPHUpHealth41.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLNBabylon1,89525.61 million15.75 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableEUDAEUDA Health237.16 millionN/ANot OptionableUPHUpHealth61117.78 million10.44 millionOptionableBTTX, UPH, EUDA, and BBLN HeadlinesRecent News About These CompaniesNewsmaker: Navigating a long, bumpy road to successFebruary 20, 2025 | bizjournals.comGlocal Healthcare Systems seeks $200 million in damages from US-based UpHealth HoldingsNovember 7, 2024 | telegraphindia.comTAppeal Filed Against Ex-SEBI Chief in US State Court Over Rs. 925 Crore Dispute By Uphealth HoldingsNovember 1, 2024 | ndtvprofit.comNBharatPe and Ashneer Grover Reach SettlementSeptember 30, 2024 | moneylife.inMUS court grants relief to former SEBI Chairman M Damodaran, vacates $25 million arbitral awardSeptember 26, 2024 | barandbench.comBUS court sets aside Arbitral Tribunal’s $25 million damages against former SEBI chiefSeptember 26, 2024 | thehindubusinessline.comUS$25mn Arbitral Award against SEBI's Ex-chief M Damodaran Set Aside by US Court in Glocal-UpHealth MatterSeptember 26, 2024 | moneylife.inMUS court sets aside arbitration tribunal's direction, clears former Sebi chief of $25-mn claim in Glocal disputeSeptember 26, 2024 | moneycontrol.comUS Court Sets Aside $25-Million Arbitral Award Against Former SEBI Chairperson Meleveetil DamodaranSeptember 26, 2024 | ndtvprofit.comNNew US Healthcare Interpreting Giant Emerges as Cloudbreak Buys Voyce, Rebrands as EquitiAugust 29, 2024 | slator.comSVestar among PE-firms hungry for foodservice; SFW sells Micromeritics at ‘strong valuation’; GTCR-backed Cloudbreak snaps up VoyceAugust 24, 2024 | pehub.comLatest Case Law Related to IBC – April to June 2023August 16, 2024 | taxguru.inTIs Uphealth Inc's Stock (UPH) a Good Investment?August 7, 2024 | aaii.comAHealth Minister confirms jobs will be cut amid Health NZ shake-upJuly 23, 2024 | newstalkzb.co.nzNCEO of bankrupt health company resignsJuly 19, 2024 | bizjournals.comUpHealth Announces CEO Transition and Organizational ChangesJuly 15, 2024 | prnewswire.comFiling Information In Sealed Covers For Enforcement Of Arbitral Award Is Contrary To Natural Justice: Calcutta High CourtMay 24, 2024 | livelaw.inLIs India the promised arbitration hub or an enforcement/execution nightmare?May 23, 2024 | barandbench.comBCalcutta HC dismisses Glocal Healthcare's pleas seeking to submit affidavits of assets in ‘sealed cover’May 22, 2024 | punjabnewsexpress.comPCalcutta HC dismisses Glocal Healthcare's pleas seeking to submit affidavits of assets in ‘sealed coMay 22, 2024 | daijiworld.comDMedia Sentiment Over TimeBTTX, UPH, EUDA, and BBLN Company DescriptionsBabylon NYSE:BBLNBabylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 07/16/2025 02:47 PM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.EUDA Health NASDAQ:EUDA$3.25 +0.02 (+0.62%) Closing price 07/16/2025 03:59 PM EasternExtended Trading$3.30 +0.04 (+1.38%) As of 07/16/2025 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.UpHealth NYSE:UPHUpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
